Ignite Creation Date:
2024-07-17 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06479213
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-06-18
Brief Title:
REACH Restore Energy Activity Can Help Lupus Study
Sponsor:
Tufts Medical Center
Organization:
Tufts Medical Center
Study Overview
Official Title:
REACH Restore Energy Activity Can Help Lupus Study
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REACH
Brief Summary:
The goal of this clinical trial is to pilot test the REACH peer coaching program for fatigue in people with systemic lupus erythematosus The main questions it aims to answer are
1 Is the REACH program feasible and acceptable to participants
2 What is the impact of the REACH program on fatigue
Researchers will compare the REACH peer coaching program to the REACH mobile health application to see if the REACH program works to reduce fatigue
Participants will
Use the REACH mobile health application to set weekly movement goals and log daily physical activity
Meet weekly with their REACH peer coach if they have one to talk about their movement goals and progress
Complete weekly symptom surveys
Complete study surveys when they start the program in the middle of the program at the end of the program and 12 weeks after the program ends
Participate in an interview to provide feedback on the program
1 Is the REACH program feasible and acceptable to participants
2 What is the impact of the REACH program on fatigue
Researchers will compare the REACH peer coaching program to the REACH mobile health application to see if the REACH program works to reduce fatigue
Participants will
Use the REACH mobile health application to set weekly movement goals and log daily physical activity
Meet weekly with their REACH peer coach if they have one to talk about their movement goals and progress
Complete weekly symptom surveys
Complete study surveys when they start the program in the middle of the program at the end of the program and 12 weeks after the program ends
Participate in an interview to provide feedback on the program
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| K23AR078177 | NIH | None | None |